<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7496561\results\search\zoonosis\results.xml">
  <result pre="respiratory syndrome coronavirus 2 (SARS-CoV-2), previously known as 2019-nCoV], the" exact="coronavirus disease 2019" post="(COVID-19) was first detected in Wuhan, China. Since then,"/>
  <result pre="numerous outbreaks of diseases in the past, including Ebola, cholera,Â" exact="Middle East respiratory syndrome" post="(MERS), the novel coronavirus pandemic has undoubtedly proven to"/>
  <result pre="mitigate the severity of this crisis. The specific symptomatology of" exact="coronavirus disease 2019" post="(COVID-19) has been challenging to define with the emergence"/>
  <result pre="patients, thrombocytopenia in 36.2%, and leukopenia in 33.7% people [2]." exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) is a betacoronavirus belonging to the"/>
  <result pre="severe acute respiratory syndrome (SARS) outbreak in 2002 and the" exact="Middle East respiratory syndrome" post="coronavirus (MERS CoV), which caused the MERS outbreak in"/>
  <result pre="caused the MERS outbreak in 2012. The severity of the" exact="SARS-CoV-2 infection," post="when compared to that of SARS and MERS, shows"/>
  <result pre="discuss the potential for repurposing existing antiviral agents to treat" exact="SARS-CoV-2 infection" post="with their site of action as shown in Figure"/>
  <result pre="In 2017, Gilead Sciences developed RDV for the treatment of" exact="Ebola" post="virus infection. It is a broad-spectrum drug having antiviral"/>
  <result pre="for prevention and/or treatment gathered interest during the West African" exact="Ebola" post="outbreak. Various other infections caused by West Nile Virus,"/>
  <result pre="behind use: in a majority of seriously ill patients of" exact="COVID 19," post="the leading cause of death has been found to"/>
  <result pre="focussing on stopping ACE inhibitors and ARBs for patients with" exact="COVID 19." post="Data on the renin-angiotensin system (RAS) drugs acting on"/>
  <result pre="angiotensin-converting enzyme;Â SARS-CoV-2:Â severe acute respiratory syndrome coronavirus 2;Â COVID-19:Â" exact="coronavirus disease 2019" post="Intervention NCT ID No. of participants Duration Phase Sponsor"/>
  <result pre="that is the diagnostic questionPostgrad Med JColemanJJManaviKMarsonEJBotkaiAHSapeyE39239896202032522844 2Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J MedGuanWJNiZYHuYet al.17081720382202032109013 3A novel coronavirus"/>
  <result pre="COVID-19 outbreakCurr BiolZhangTWuQZhangZ1346135130202032197085 8The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreak - an update on the statusMil Med"/>
  <result pre="release syndromeOncologistLeRQLiLYuanWet al.94394723201829622697 37Can we use interleukin-6 (IL-6) blockade for" exact="coronavirus disease 2019" post="(COVID-19)-induced cytokine release syndrome (CRS)?J AutoimmunLiuBLiMZhouZGuanXXiangY102452111202032291137 38Coronavirus disease 2019"/>
  <result pre="of anti-inflammatory drugs in the treatment of people with severe" exact="coronavirus disease 2019" post="(COVID-19): the perspectives of clinical immunologists from ChinaClin ImmunolZhangWZhaoYZhangFet"/>
 </snippets>
</snippetsTree>
